1. Home
  2. WAFU vs TCRT Comparison

WAFU vs TCRT Comparison

Compare WAFU & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wah Fu Education Group Limited

WAFU

Wah Fu Education Group Limited

HOLD

Current Price

$1.72

Market Cap

7.2M

Sector

Real Estate

ML Signal

HOLD

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

HOLD

Current Price

$3.22

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAFU
TCRT
Founded
1999
1998
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
7.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
WAFU
TCRT
Price
$1.72
$3.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.2K
53.4K
Earning Date
01-01-0001
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,186,645.00
$6,000.00
Revenue This Year
N/A
$5,680,500.00
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.22
$1.31
52 Week High
$7.49
$6.20

Technical Indicators

Market Signals
Indicator
WAFU
TCRT
Relative Strength Index (RSI) 57.74 43.02
Support Level $1.52 $3.13
Resistance Level $1.67 $4.04
Average True Range (ATR) 0.09 0.33
MACD 0.01 -0.06
Stochastic Oscillator 69.14 23.28

Price Performance

Historical Comparison
WAFU
TCRT

About WAFU Wah Fu Education Group Limited

Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.

Share on Social Networks: